
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 17.670 | 17.670 | 0.000 |
Bonds | 82.330 | 82.330 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 100.806 | 17.065 |
Price to Book | 7.250 | 2.195 |
Price to Sales | 3.525 | 1.582 |
Price to Cash Flow | - | 9.762 |
Dividend Yield | - | 2.739 |
5 Years Earnings Growth | - | 11.134 |
Name | Net % | Category Average |
---|---|---|
Government | 56.679 | 35.348 |
Corporate | 15.775 | 46.928 |
Securitized | 13.952 | 6.787 |
Cash | 13.192 | 17.645 |
Derivative | 0.402 | 11.044 |
Number of long holdings: 117
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Bundei 0,5% Ap30 Eur | DE0001030559 | 4.60 | 100.72 | -0.01% | |
Obligacionesei 1% Nv30 Eur | ES00000127C8 | 3.43 | 102.35 | +0.05% | |
Germany (Federal Republic Of) 2.2% | DE000BU22080 | 2.89 | - | - | |
Finland 1.375 15-Apr-2027 | FI4000527551 | 2.15 | 99.360 | +0.02% | |
GlaxoSmithKline Capital PLC 4% | XS0222383027 | 1.99 | - | - | |
Germany 2.4 18-Apr-2030 | DE000BU25042 | 1.81 | 101.700 | -0.02% | |
Belgium (Kingdom Of) 0% | BE0312805774 | 1.78 | - | - | |
Deutsche Kreditbank AG 0.5% | DE000DKB0432 | 1.66 | - | - | |
Netherlands 0 15-Jan-2029 | NL0015000LS8 | 1.64 | 92.910 | -0.10% | |
Netherlands .25 15-Jul-2029 | NL0013332430 | 1.64 | 92.760 | -0.05% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Flossbach von Storch Bond Opportuni | 6.25B | 0.65 | 2.20 | 3.03 | ||
Flossbach von Storch Bond Opportune | 6.25B | 0.52 | 1.69 | 2.51 | ||
LU1481584016 | 6.25B | 0.65 | 2.19 | 3.03 | ||
LU1481583711 | 6.25B | 0.52 | 1.68 | 2.51 | ||
LU1748855837 | 6.25B | 0.60 | 1.99 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review